v3.26.3
LEASES (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 25, 2024
Aug. 31, 2026
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Lessee, Lease, Description [Line Items]              
Operating lease right-of-use assets     $ 164,115   $ 164,115   $ 23,360
Right-of-use asset obtained in exchange for operating lease liability         $ 167,967  
Operating lease, option to extend   In August 2026, the Company exercised its option under its existing office sublease with Saptalis Pharmaceuticals, LLC, which commenced on October 1, 2023, with an initial term ending July 31, 2026, to extend the term for an additional five years through August 31, 2031. Monthly rent during the extended term is $3,600 for the first 12 months, increasing 4% annually beginning August 1, 2027.          
Monthly rent   $ 3,600          
Weighted-average discount rate     15.50%   15.50%   15.50%
Location, Statement of Income, Balance [Axis]: us-gaap:GeneralAndAdministrativeExpense              
Lessee, Lease, Description [Line Items]              
Operating lease expense     $ 11,338 $ 8,906 $ 25,077 $ 68,103  
Merger Agreement [Member] | Scienture Inc [Member]              
Lessee, Lease, Description [Line Items]              
Operating lease right-of-use assets $ 61,578            
Right-of-use asset obtained in exchange for operating lease liability $ 61,886